Five Purdue Pharma LP patents covering an abuse-resistant OxyContin formulation that reduces the opiod’s toxicity are invalid ...
BOSTON (AP) — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its ...
A consulting giant that helped fuel the United States’ deadly opioid epidemic agreed to pay a massive settlement to avoid ...
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe ...
The major consulting firm McKinsey & Company will pay $650 million to resolve criminal and civil investigations into its ...
The author writes "This fall, the bankruptcy court extended the preliminary injunction for the thirty-seventh time and ...
As the U.S. opioid crisis deepened, Medicare plans administered by UnitedHealth and CVS Health were a top source of OxyContin ...
Global consulting firm McKinsey & Company agreed Friday to pay $650 million to resolve criminal and civil investigations into the advice it provided to opioids manufacturer Purdue Pharma.
McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids ...
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how ...
BOSTON — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback